173 related articles for article (PubMed ID: 32145257)
1. [
Shao T; Chen Z; Belov V; Wang X; Rwema SH; Kumar V; Fu H; Deng X; Rong J; Yu Q; Lang L; Lin W; Josephson L; Samir AE; Chen X; Chung RT; Liang SH
J Hepatol; 2020 Jul; 73(1):161-169. PubMed ID: 32145257
[TBL] [Abstract][Full Text] [Related]
2. Assessing activation of hepatic stellate cells by (99m)Tc-3PRGD2 scintigraphy targeting integrin αvβ3: a feasibility study.
Zhang X; Xin J; Shi Y; Xu W; Yu S; Yang Z; Liu C; Cao L; Guo Q
Nucl Med Biol; 2015 Mar; 42(3):250-5. PubMed ID: 25530210
[TBL] [Abstract][Full Text] [Related]
3. Molecular imaging of hepatic stellate cell activity by visualization of hepatic integrin αvβ3 expression with SPECT in rat.
Li F; Song Z; Li Q; Wu J; Wang J; Xie C; Tu C; Wang J; Huang X; Lu W
Hepatology; 2011 Sep; 54(3):1020-30. PubMed ID: 21618580
[TBL] [Abstract][Full Text] [Related]
4. Platelet-derived growth factor receptor β-targeted positron emission tomography imaging for the noninvasive monitoring of liver fibrosis.
Li Z; Yang H; Li X; She T; Tao Z; Zhong Y; Su T; Feng Y; Shi Q; Li L; Tian R; Wang S; Cheng J; Cai H; Lu X
Eur J Nucl Med Mol Imaging; 2024 May; 51(6):1530-1543. PubMed ID: 38189910
[TBL] [Abstract][Full Text] [Related]
5. Imaging Fibrogenesis in a Diet-Induced Model of Nonalcoholic Steatohepatitis (NASH).
Hartimath SV; Boominathan R; Soh V; Cheng P; Deng X; Chong YC; Yong FF; Tan PW; Han W; Robins EG; Goggi JL
Contrast Media Mol Imaging; 2019; 2019():6298128. PubMed ID: 31866798
[TBL] [Abstract][Full Text] [Related]
6. Molecular magnetic resonance imaging of activated hepatic stellate cells with ultrasmall superparamagnetic iron oxide targeting integrin αvβ₃ for staging liver fibrosis in rat model.
Zhang C; Liu H; Cui Y; Li X; Zhang Z; Zhang Y; Wang D
Int J Nanomedicine; 2016; 11():1097-108. PubMed ID: 27051285
[TBL] [Abstract][Full Text] [Related]
7. A pilot study imaging integrin αvβ3 with RGD PET/CT in suspected lung cancer patients.
Gao S; Wu H; Li W; Zhao S; Teng X; Lu H; Hu X; Wang S; Yu J; Yuan S
Eur J Nucl Med Mol Imaging; 2015 Dec; 42(13):2029-37. PubMed ID: 26153145
[TBL] [Abstract][Full Text] [Related]
8. Longitudinal PET imaging of muscular inflammation using 18F-DPA-714 and 18F-Alfatide II and differentiation with tumors.
Wu C; Yue X; Lang L; Kiesewetter DO; Li F; Zhu Z; Niu G; Chen X
Theranostics; 2014; 4(5):546-55. PubMed ID: 24672585
[TBL] [Abstract][Full Text] [Related]
9. Pharmacological inhibition of integrin alphavbeta3 aggravates experimental liver fibrosis and suppresses hepatic angiogenesis.
Patsenker E; Popov Y; Stickel F; Schneider V; Ledermann M; Sägesser H; Niedobitek G; Goodman SL; Schuppan D
Hepatology; 2009 Nov; 50(5):1501-11. PubMed ID: 19725105
[TBL] [Abstract][Full Text] [Related]
10. Non-invasively differentiating extent of liver fibrosis by visualizing hepatic integrin αvβ3 expression with an MRI modality in mice.
Li F; Yan H; Wang J; Li C; Wu J; Wu S; Rao S; Gao X; Jin Q
Biomaterials; 2016 Sep; 102():162-74. PubMed ID: 27341269
[TBL] [Abstract][Full Text] [Related]
11. Coordinated signaling of activating transcription factor 6α and inositol-requiring enzyme 1α regulates hepatic stellate cell-mediated fibrogenesis in mice.
Xue F; Lu J; Buchl SC; Sun L; Shah VH; Malhi H; Maiers JL
Am J Physiol Gastrointest Liver Physiol; 2021 May; 320(5):G864-G879. PubMed ID: 33728997
[TBL] [Abstract][Full Text] [Related]
12. Hepatic stellate cell autophagy inhibits extracellular vesicle release to attenuate liver fibrosis.
Gao J; Wei B; de Assuncao TM; Liu Z; Hu X; Ibrahim S; Cooper SA; Cao S; Shah VH; Kostallari E
J Hepatol; 2020 Nov; 73(5):1144-1154. PubMed ID: 32389810
[TBL] [Abstract][Full Text] [Related]
13. PET monitoring angiogenesis of infarcted myocardium after treatment with vascular endothelial growth factor and bone marrow mesenchymal stem cells.
Cai M; Ren L; Yin X; Guo Z; Li Y; He T; Tang Y; Long T; Liu Y; Liu G; Zhang X; Hu S
Amino Acids; 2016 Mar; 48(3):811-820. PubMed ID: 26592497
[TBL] [Abstract][Full Text] [Related]
14. Utility of Translocator Protein (18 kDa) as a Molecular Imaging Biomarker to Monitor the Progression of Liver Fibrosis.
Hatori A; Yui J; Xie L; Kumata K; Yamasaki T; Fujinaga M; Wakizaka H; Ogawa M; Nengaki N; Kawamura K; Wang F; Zhang MR
Sci Rep; 2015 Nov; 5():17327. PubMed ID: 26612465
[TBL] [Abstract][Full Text] [Related]
15. An integrin-based nanoparticle that targets activated hepatic stellate cells and alleviates liver fibrosis.
Li Y; Pu S; Liu Q; Li R; Zhang J; Wu T; Chen L; Li H; Yang X; Zou M; Xiao J; Xie W; He J
J Control Release; 2019 Jun; 303():77-90. PubMed ID: 31004666
[TBL] [Abstract][Full Text] [Related]
16. Small-Animal SPECT/CT of the Progression and Recovery of Rat Liver Fibrosis by Using an Integrin αvβ3-targeting Radiotracer.
Yu X; Wu Y; Liu H; Gao L; Sun X; Zhang C; Shi J; Zhao H; Jia B; Liu Z; Wang F
Radiology; 2016 May; 279(2):502-12. PubMed ID: 26669696
[TBL] [Abstract][Full Text] [Related]
17. A comparison study of dynamic [
Pan Y; Dang H; Zhou H; Fu H; Wu S; Liu H; Zhang J; Wang R; Tian Y; Xu B
J Cancer Res Clin Oncol; 2024 Apr; 150(4):208. PubMed ID: 38647690
[TBL] [Abstract][Full Text] [Related]
18. Relationship Between Clinicopathological Characteristics and PET/CT Uptake in Esophageal Squamous Cell Carcinoma: [
Dong Y; Wei Y; Chen G; Huang Y; Song P; Liu S; Zheng J; Cheng M; Yuan S
Mol Imaging Biol; 2019 Feb; 21(1):175-182. PubMed ID: 29869060
[TBL] [Abstract][Full Text] [Related]
19. Stereotactic Comparison Study of (18)F-Alfatide and (18)F-FDG PET Imaging in an LLC Tumor-Bearing C57BL/6 Mouse Model.
Wei YC; Gao Y; Zhang J; Fu Z; Zheng J; Liu N; Hu X; Hou W; Yu J; Yuan S
Sci Rep; 2016 Jun; 6():28757. PubMed ID: 27350554
[TBL] [Abstract][Full Text] [Related]
20. [18F]AlF-ND-bisFAPI PET imaging of fibroblast activation protein as a biomarker to monitor the progression of liver fibrosis.
Li H; Dai R; Huang Y; Zhong J; Yan Q; Yang J; Hu K; Zhong Y
Hepatol Commun; 2024 Apr; 8(4):. PubMed ID: 38466884
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
